Davis R M Inc. Has $20.91 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Davis R M Inc. lessened its holdings in CME Group Inc. (NASDAQ:CME) by 5.1% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 94,766 shares of the financial services provider’s stock after selling 5,128 shares during the quarter. Davis R M Inc.’s holdings in CME Group were worth $20,910,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CME. Y.D. More Investments Ltd acquired a new position in shares of CME Group during the 2nd quarter worth approximately $36,000. McClarren Financial Advisors Inc. grew its position in CME Group by 66.1% during the second quarter. McClarren Financial Advisors Inc. now owns 196 shares of the financial services provider’s stock worth $39,000 after buying an additional 78 shares in the last quarter. Asset Dedication LLC increased its stake in CME Group by 515.2% during the 2nd quarter. Asset Dedication LLC now owns 203 shares of the financial services provider’s stock worth $40,000 after acquiring an additional 170 shares during the period. Thurston Springer Miller Herd & Titak Inc. raised its holdings in CME Group by 62.2% in the 3rd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after acquiring an additional 74 shares in the last quarter. Finally, Bank & Trust Co bought a new stake in shares of CME Group during the 2nd quarter valued at $76,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts recently commented on CME shares. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research report on Thursday, October 24th. The Goldman Sachs Group raised their target price on shares of CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Oppenheimer upped their price target on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a report on Thursday, October 24th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Piper Sandler upped their target price on CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday, October 28th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of “Hold” and an average target price of $224.47.

CME Group Price Performance

CME Group stock opened at $229.04 on Monday. The stock has a 50-day moving average price of $223.64 and a two-hundred day moving average price of $211.08. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.74. The company has a market capitalization of $82.54 billion, a PE ratio of 24.08, a P/E/G ratio of 5.28 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.03. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The business had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the business earned $2.25 EPS. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. Analysts expect that CME Group Inc. will post 10.22 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.01%. CME Group’s payout ratio is 48.37%.

Insider Buying and Selling

In other news, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This trade represents a 5.38 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 12.01 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,621 shares of company stock valued at $3,441,063 in the last three months. Insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.